Bringing New Science, and New Partners, Into the Drug Development Process
Today’s evolving healthcare environment calls for more collaboration in bringing drugs to market
The Role of Health Coaching in Adherence and Supporting Patients 'Beyond the Pill'
GSK invests in online resources to address ‘the whole patient’
How to Transform REMS Into an Opportunity to Develop a More Successful Drug Launch
Industry Revenue Management Practices Are Showing Gradual Improvement
The 7th Annual Model N survey shows that industry is struggling with the growing complexity of contracts and pricing for managed care and government programs
AmerisourceBergen Specialty Group reconfigues Cubixx medical cabinet
Wireless- and RFID-enabled refrigerator cabinet is redesigned for home, clinic use
Serialization implementations are making progress
Axway and AstraZeneca have 33 sites up and running ; Teva is pioneering generics tracking; 4Serialization brings a consortium together
Drug-shortage worries rise among healthcare providers
Gartner places Owens & Minor as No. 1 in Top 25 Healthcare Supply Chain organizations
Second annual ranking drops J&J to second place, but the company still leads among pharma mfrs
Cardinal Health to acquire Kinray, a major wholesaler in the Northeast, for $1.3 billion
Acquisition strengthens Cardinal’s presence among independent pharmacies
2010 Product Security Report
More pieces for industry-wide track-and-trace are falling into place, but there’s no rush to authenticate products
Put a 'PillStation' in the Patient's Home to Improve Medication Adherence
New device links healthcare providers to patients for reminder notifications
RFID vendor targets pharma cold-chain tracking with 'Extended Capability' temperature sensing
Storing e-pedigree data on the tag is a giveaway added value for users
AmerisourceBergen elevates Steve Collis to president and COO
Where--and what--are the illnesses accessible to drug therapy in the world?
Kantar Health expands its epidemiology databases to emerging markets, including Turkey and Mexico
Rare Diseases and Orphan Drugs Lift Pharma Innovation
As hundreds of candidate drugs receive official “orphan” status, the Orphan Drug Act gets re-examined. Meanwhile, these drugs are driving the growth of specialty pharmacy
Getting Physician Databases Right
The seemingly routine process of identifying and locating prescribing physicians is becoming a critical industry function
Technology Transfer
How Contract Manufacturers Can Help Pharma Through The Era of Divestiture
Booming Biopharma Cold-Chain Market Attracts High Industry Turnout
Record numbers of attendees and exhibitors came together at Philadelphia meeting
Pharmacos and Payers: Achieving Common Ground in a Changing Market
Emerging Payer Business Trends That Pharmacos Need to Know
Drivers in the post-healthcare-reform world
Approved labeling for tamper-resistant opioid formulations could rest on Web monitoring of drug abusers
The Navippro database, plus some artful online monitoring, could provide outcomes research—of a sort—for drug abuse
Health Reform Includes Research and Prevention
The Rising Importance of Observational Research
International efforts to standardize guidelines for observational research could move the entire field forward
Are Pharma Brands Worth Protecting?
New e-pedigree alliance forms up to address serialization implementation
Group brings together Nosco, Cognex, Acsis and Omega Design, and will support GS1 standards
OM Healthcare Logistics lands first major customer: CareFusion
New 3PL will add a second facility by year-end; stresses the economies of consolidated shipping
Global pharma market will reach $880 billion in 2011, up 5-7%, predicts IMS Health
National illicit-drug use rose by 9% in 2009, say feds
NSDUH survey shows prescription drug abuse rose by 13%, to 7.0 million individuals
ISPE issues a white paper on supply chain security
Advisory panel recommends “signal monitoring” to anticipate potential risks
Thomson Reuters partners with specialist firm to provide API manufacturing-costs estimating
Service will enable first-pass or competitive-intelligence estimating of production costs for active pharmaceutical ingredients based on patent literature